Trial Profile
Effect on the vascular endothelium function of aggressive lipid control treatment with rosuvastatin -evaluation of a vascular endothelium function by Endo-PAT 2000-
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2018
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Coronary artery disease; Hypercholesterolaemia
- Focus Biomarker; Therapeutic Use
- Acronyms EARTH
- 11 Mar 2013 New trial record